Why empowering both parties with the tools and data they need to make clinical decisions should be a top priority in the AI renaissance—to bolster patient care and improve health outcomes.
How pharma companies can make sure their corporate strategy in ESG is appealing to younger generations—and aligns with the issues this large segment of sustainability investors care about most.
How far should your digital strategy reach? Daniel King and Simon Davies offer five signs that indicate you need better digital support.
How the CIO role has transformed and strengthened against the backdrop of COVID-19.
Lessons to launch by during a pandemic—or otherwise.
In the coming year, efficiency and automation will take center stage to maximize constrained resources but balancing sensible financial management with strategic investments will be vital.
AI-enabled digital therapeutics have helped give new meaning to the term personalized medicine by tailoring not just the treatment itself, but the way that treatment is managed to the individual characteristics of each patient.
Life sciences companies are collaborating more with technology enterprises, universities, and other groups, which is changing the landscape of the industry.
Rise in demand for sustainable practices forces industry to be more proactive.
Hannah Schofield and Lavan Thasarathakumar discuss what blockchain is, how it could help improve pharmaceutical supply chains, and the COVID-19 vaccine supply chain in particular, and touches on where we are already seeing blockchain technology being used in this area.
*** Wednesday, February 3, 2021 at 1pm EST | 12pm CST | 10am PST*** Industry leading ERP & MRP Solutions for Pharma. Join our informative Webinar with AdaptaLogix, the fastest growing NetSuite & Oracle partner, to learn more about the solutions that have been developed to meet mid-market pharma’s unmet needs. ***On demand available after final airing until Feb. 3, 2022***
Delivering value with enterprise program management.
Leslie Rotz and Todd Parker outline four major steps in the Medical Affairs digital transformation journey.
How PREP Act protections will apply to potential COVID-19 vaccine-related claims.
Sales and marketing effectiveness of speaker programs is often one of the least understood aspects in the industry. Yet, pharma brands spent over $12.5 billion in 2022 to engage and influence with HCP-to-HCP activities. CMS’s Open Payments data is an overlooked tool to get greater visibility and create more strategic opportunities—while also enriching compliance. This paper explores how to filter and pinpoint critical data sets using browser-based technology to gain marketing insights from this data and measure competitiveness.¬
As the life sciences industry enters this next stage of growth, capitalizing on AI and digital transformation will be key to propelling innovation and ensuring that companies are prepared to tackle the challenges ahead.
Pharma should be the ‘glue’ that bonds healthcare organizations together to solve society’s most pressing challenges.
What can the industry do to create more equality in our healthcare system?
A roadmap for cohering patient perspectives.
Thursday, November 11, 2021 at 11am, EST | 8am PST| 4pm GMT | 5pm CET If you want to transform to a secure, scalable SaaS platform with a modern, intuitive interface for complete control in configuring workflows for your ever growing list of techniques, modalities, and data types, this webinar is for you.
Having proved its efficacy against COVID-19, mRNA technology is positioned to combat another insidious human adversary: cancer.
Contrasting the view of heart failure patients as seen from the perspectives of two large but distinct sources of real-world data: the Veradigm Cardiology Registry and Practice Fusion
Gaps remain in the pre-approval information process leave payers without all of the information they need to make the proper decisions.